Cargando…
Does early resection of presumed low-grade glioma improve survival? A clinical perspective
Early resection is standard of care for presumed low-grade gliomas. This is based on studies including only tumors that were post-surgically confirmed as low-grade glioma. Unfortunately this does not represent the clinicians’ situation wherein he/she has to deal with a lesion on MRI that is suspect...
Autores principales: | Wijnenga, Maarten M. J., Mattni, Tariq, French, Pim J., Rutten, Geert-Jan, Leenstra, Sieger, Kloet, Fred, Taphoorn, Martin J. B., van den Bent, Martin J., Dirven, Clemens M. F., van Veelen, Marie-Lise, Vincent, Arnaud J. P. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495869/ https://www.ncbi.nlm.nih.gov/pubmed/28401374 http://dx.doi.org/10.1007/s11060-017-2418-8 |
Ejemplares similares
-
Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma
por: Wijnenga, Maarten M. J., et al.
Publicado: (2018) -
PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients
por: Draaisma, Kaspar, et al.
Publicado: (2015) -
Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints
por: van der Meer, Pim B., et al.
Publicado: (2021) -
Differences in spatial distribution between WHO 2016 low-grade glioma molecular subgroups
por: Wijnenga, Maarten M J, et al.
Publicado: (2019) -
Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation
por: Wijnenga, Maarten M J, et al.
Publicado: (2023)